Yoffe Investment Management LLC Acquires New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Yoffe Investment Management LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,056 shares of the healthcare conglomerate's stock, valued at approximately $1,040,000. UnitedHealth Group makes up approximately 1.5% of Yoffe Investment Management LLC's holdings, making the stock its 13th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. Finally, AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH traded down $0.58 during mid-day trading on Tuesday, reaching $294.99. 20,069,744 shares of the company's stock traded hands, compared to its average volume of 6,655,522. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a market capitalization of $267.60 billion, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The business's 50-day moving average price is $448.25 and its 200-day moving average price is $501.48. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the firm earned $6.91 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. Barclays reduced their price target on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. KeyCorp dropped their price objective on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Robert W. Baird dropped their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Raymond James downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, Wells Fargo & Company lowered their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $441.87.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.